Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-037492
Filing Date
2025-02-27
Accepted
2025-02-27 06:03:28
Documents
8
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 6-K d841699d6k.htm 6-K 9652
2 EX-99.1 d841699dex991.htm EX-99.1 501901
3 GRAPHIC g841699g0226173703211.jpg GRAPHIC 2017
4 GRAPHIC g841699g0226180950266.jpg GRAPHIC 3934
5 GRAPHIC g841699g0226200808193.jpg GRAPHIC 2054
6 GRAPHIC g841699g0226200808419.jpg GRAPHIC 3040
7 GRAPHIC g841699img3.jpg GRAPHIC 7729
8 GRAPHIC g841699img4.jpg GRAPHIC 12459
  Complete submission text file 0001193125-25-037492.txt   556714
Mailing Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000
Business Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 612 8315 7003
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 25672583
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)